Mycoplasma meleagridis: Turkey Airsacculitis and Leg Deformities – Hatchery Transmission and Control

Introduction

Mycoplasma meleagridis is a bacterial pathogen of turkeys that causes significant economic losses in commercial production. This organism is primarily associated with airsacculitis and skeletal abnormalities, particularly in young poults. The infection is efficiently transmitted through the hatchery, where vertical transmission from infected breeder flocks perpetuates the disease cycle. Despite decades of research, M. meleagridis remains a challenge due to its ability to evade immune clearance and its synergistic interactions with other respiratory pathogens.

This article provides an exhaustive clinical reference on the etiology, epidemiology, pathology, diagnostics, treatment, and control of Mycoplasma meleagridis in turkeys, with emphasis on hatchery-mediated spread and preventive management.

Etiology and Genomic Characteristics

Mycoplasma meleagridis is a member of the class Mollicutes, characterized by the absence of a cell wall and a reduced genome. The type strain 17529 has been fully sequenced, revealing a genome of approximately 800 kilobases with a low G+C content [1]. This genome encodes a limited set of metabolic pathways, reflecting the organism's parasitic lifestyle and dependence on host-derived nutrients.

A notable virulence determinant is the Mm19 major surface nuclease, which belongs to the RE_AlwI superfamily of endonucleases [2]. This enzyme is involved in DNA degradation, potentially facilitating immune evasion and nutrient acquisition. The presence of such surface nucleases is a common feature among pathogenic mycoplasmas, enabling them to modulate host inflammatory responses.

Epidemiology and Hatchery Transmission

Mycoplasma meleagridis turkey airsacculitis leg deformities hatchery transmission is a classic example of vertical dissemination. Infected breeder hens harbor the organism in their oviducts, leading to contamination of eggs. During incubation and hatching, poults are exposed through infected yolk sacs and respiratory droplets. The organism can also spread horizontally among poults in crowded hatcher trays.

The prevalence of infection in commercial turkey flocks varies widely. In a survey conducted in Saskatchewan, skeletal disorders linked to M. meleagridis were identified in multiple flocks, underscoring the endemic nature of the pathogen [3]. Differences in infection rates between cull and normal poults at one day of age indicate that hatchery transmission favors the more heavily colonized individuals [4]. Cull poults exhibited higher isolation rates, suggesting that early infection compromises viability.

Transmission can also occur via contaminated equipment and personnel. The organism survives well in moist environments and on fomites, making biosecurity critical in hatcheries. Mixed infections with other avian mycoplasmas, such as Mycoplasma gallisepticum and Mycoplasma synoviae, exacerbate clinical outcomes [5].

Clinical Signs: Airsacculitis and Leg Deformities

Two hallmark presentations of M. meleagridis infection are respiratory disease and skeletal abnormalities.

Airsacculitis

In experimentally infected day-old poults, airsacculitis develops within 7 to 14 days post-inoculation [6, 7]. Clinical signs include dyspnea, gasping, and increased mortality. Affected birds often exhibit a characteristic "snicking" sound due to tracheal irritation. The lesions are primarily confined to the thoracic and abdominal air sacs, which become thickened, opaque, and filled with caseous exudate.

The severity of airsacculitis is influenced by concurrent infections. In gnotobiotic poults, M. meleagridis alone produces mild lesions, but co-infection with Escherichia coli induces severe, complicated airsacculitis with fibrinous exudation and high mortality [8]. This synergy is a major concern in commercial operations where E. coli is endemic (see Escherichia coli in Chickens and Poultry Products).

Leg Deformities

Skeletal manifestations include chondrodystrophy, tibial dyschondroplasia, and angular limb deformities. These conditions are most apparent in growing poults between 2 and 4 weeks of age. Affected birds may show reluctance to stand, splay-legged posture, and stunted growth. The pathogenesis involves direct invasion of the growth plates and disruption of endochondral ossification.

The term "green-liver osteomyelitis complex" has been associated with chronic M. meleagridis infection, although other bacteria such as Staphylococcus aureus and E. coli may also be involved [9]. In the reported study, lesions included femoral head necrosis and synovitis, with M. meleagridis isolated from bone lesions in some cases.

Pathology and Histopathology

Gross pathological changes in the respiratory tract consist of catarrhal to fibrinous exudate in the trachea, primary bronchi, and air sacs. Histologically, the lesion is a lymphoplasmacytic inflammation with epithelial hyperplasia and desquamation. In the air sacs, there is edema, fibrin deposition, and infiltration of heterophils and macrophages [6].

Skeletal lesions show degeneration of chondrocytes in the hypertrophic zone of the growth plate, with microfractures and fibrosis. In chronic cases, osteomyelitis and sequestrum formation occur. The bacterium can be demonstrated by special stains (e.g., Giemsa) or immunohistochemistry in affected tissues.

Pathogenesis and Host Interactions

The pathogenic mechanisms of M. meleagridis involve adhesion to respiratory and synovial epithelia, mediated by surface adhesins. The Mm19 nuclease may facilitate tissue damage by degrading host extracellular DNA and nucleosomes, thereby promoting inflammation [2]. The organism also stimulates a strong humoral immune response, but this does not lead to clearance because of antigenic variation and intracellular survival in epithelial cells.

In the hatchery setting, yolk sac infection provides a reservoir for sustained bacteremia. The organism then localizes to serosal surfaces (air sacs, peritoneum) and joints. The incubation period is approximately 5 to 10 days, after which clinical signs appear.

Diagnostic Approaches

Diagnosis of M. meleagridis infection relies on a combination of culture, serology, and molecular methods.

Culture and Isolation

The organism is fastidious and requires specialized media such as Frey's medium or Hayflick's medium supplemented with 10% to 20% horse serum and 10% fresh yeast extract. Colonies appear as typical "fried egg" morphology after 3 to 7 days of incubation at 37°C in a humidified CO2 environment. Isolation from air sacs, trachea, or yolk sacs of affected poults yields the highest success rates.

Serology

Serological tests include the serum plate agglutination (SPA) test and enzyme-linked immunosorbent assay (ELISA). The ELISA is more sensitive and specific, but cross-reactions with other avian mycoplasmas can occur. For detailed interpretation of ELISA-based diagnostics, see Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus. In turkeys, positive serology indicates exposure but not necessarily active infection.

Molecular Detection

Polymerase chain reaction (PCR) targeting the 16S rRNA gene or the Mm19 nuclease gene provides rapid, specific detection [2]. Real-time PCR assays quantify bacterial load and are particularly useful for screening hatchery samples. High-throughput sequencing can be employed for epidemiological investigations, but commercial tests are not widely available; generic real-time PCR platforms are used.

Table 1 summarizes diagnostic test characteristics.

Treatment and Antimicrobial Therapy

Antimicrobial treatment of M. meleagridis infections is challenging because mycoplasmas lack a cell wall, rendering beta-lactams ineffective. The drug of choice historically has been the combination of lincomycin and spectinomycin (L-S). Several studies have demonstrated the efficacy of L-S water medication in reducing airsacculitis lesions and mortality in commercial turkey poults [10, 11]. In field trials, administration of L-S at 50 mg/kg body weight for 3 to 5 days significantly decreased lesion scores and improved growth performance.

However, antimicrobial resistance is an emerging concern. Routine susceptibility testing is not standardized for mycoplasmas, but reduced susceptibility to tylosin and oxytetracycline has been reported. Therefore, treatment should be guided by sensitivity profiles where possible.

Use of Immune Gamma Globulin

An alternative approach is passive immunization using specific immune gamma globulin. In a controlled study, administration of gamma globulin from hyperimmune turkeys to day-old poults provided partial protection against experimental airsacculitis [12]. Although this strategy is not commercially viable, it illustrates the potential for immunological interventions.

Control and Prevention Strategies

Control of M. meleagridis turkey airsacculitis leg deformities hatchery transmission requires a comprehensive biosecurity and management program. The following measures are recommended.

Hatchery Management

1. Breeder flock monitoring. All breeder flocks should be tested for M. meleagridis using serology and PCR. Positive flocks should be culled or replaced.
2. Egg sanitation. Eggs should be fumigated with formaldehyde or treated with disinfectants effective against mycoplasmas (e.g., quaternary ammonium compounds, hydrogen peroxide).
3. Hatchery hygiene. Incubators, hatchers, and transport vehicles must be cleaned and disinfected between batches. Rodent and insect control is essential.
4. Single-age rearing. All-in/all-out management prevents carryover of infection between age groups.
5. Antimicrobial prophylaxis. In high-risk situations, L-S medication in the first few days of life reduces early mortality [11, 10]. This should be used judiciously to minimize resistance.

Biosecurity in Growing Farms

• Segregation of turkey flocks from other avian species (e.g., chickens, ducks) to prevent interspecies transmission.
• Restricted personnel movement and use of dedicated footwear and coveralls.
• Routine cleaning of feeders and drinkers with disinfectants.

Vaccination

No commercial vaccine is currently available for M. meleagridis. Autogenous bacterins have been used experimentally but with inconsistent results. The development of a live attenuated vaccine may be feasible given the genome sequence information [1], but field trials are lacking.

Eradication

Elimination of M. meleagridis from breeder flocks is possible through strict serological monitoring and removal of seropositive birds. In several countries, such programs have achieved freedom from infection. However, in areas with high farm density, reinfection is common.

Decision Tree for Hatchery Control

The following Mermaid diagram outlines a decision framework for managing M. meleagridis in hatcheries.

flowchart TD
    A[Monitor breeder flocks], > B{Serology/PCR positive?}
    B, Yes, > C[Cull or replace flock]
    B, No, > D[Collect eggs from negative flocks]
    C, > D
    D, > E[Disinfect eggs pre-incubation]
    E, > F[Incubate in clean hatcher]
    F, > G[Test representative poults post-hatch]
    G, > H{Positive result?}
    H, Yes, > I[Apply L-S water medication]
    H, No, > J[Release poults to farm]
    I, > J
    J, > K[Monitor clinical signs on farm]
    K, > L{Signs of airsacculitis or leg deformities?}
    L, Yes, > M[Diagnostic investigation and treatment]
    L, No, > N[Continue routine surveillance]

References

[1] Yacoub E, Sirand-Pugnet P, Blanchard A, et al. Genome Sequence of Mycoplasma meleagridis Type Strain 17529. Genome Announc. 2015. https://pubmed.ncbi.nlm.nih.gov/25999574/

[2] Yacoub E, Ben Abdelmoumen Mardassi B. Mm19, a Mycoplasma meleagridis Major Surface Nuclease that Is Related to the RE_AlwI Superfamily of Endonucleases. PLoS One. 2016. https://pubmed.ncbi.nlm.nih.gov/27010566/

[3] Riddell C. A survey of skeletal disorders in five turkey flocks in Saskatchewan. Can J Comp Med. 1980. https://pubmed.ncbi.nlm.nih.gov/7427775/

[4] Fox ML, Bigland CH. Differences between cull and normal turkeys in natural infection with Mycoplasma meleagridis at one day of age. Can J Comp Med. 1970. https://pubmed.ncbi.nlm.nih.gov/4249088/

[5] Rhoades KR. Turkey airsacculitis: effect of mixed mycoplasmal infections. Avian Dis. 1981. https://pubmed.ncbi.nlm.nih.gov/7271649/

[6] Arya PL, Sauter JH, Pomeroy BS. Pathogenesis and histopathology of airsacculitis in turkeys produced by experimental inoculation of day-old poults with Mycoplasma meleagridis. Avian Dis. 1971. https://pubmed.ncbi.nlm.nih.gov/4926594/

[7] Rosenfeld LE, Grimes TM. Natural and experimental cases of airsacculitis associated with Mycoplasma meleagridis infection in turkeys. Aust Vet J. 1972. https://pubmed.ncbi.nlm.nih.gov/5068806/

[8] Saif YM, Moorhead PD, Bohl EH. Mycoplasma meleagridis and Escherichia coli infections in germfree and specific-pathogen-free turkey poults: production of complicated airsacculitis. Am J Vet Res. 1970. https://pubmed.ncbi.nlm.nih.gov/4097061/

[9] Bayyari GR, Huff WE, Norton RA, et al. A longitudinal study of green-liver osteomyelitis complex in commercial turkeys. Avian Dis. 1994. https://pubmed.ncbi.nlm.nih.gov/7702507/

[10] Hamdy AH, Saif YM, Kasson CW. Efficacy of lincomycin-spectinomycin water medication on Mycoplasma meleagridis airsacculitis in commercially reared turkey poults. Avian Dis. 1982. https://pubmed.ncbi.nlm.nih.gov/6213222/

[11] Hamdy AH, Saif YM, Kleven SH, et al. Efficacy of Linco-Spectin medication on mycoplasma meleagridis airsacculitis in turkey poults. Avian Dis. 1979. https://pubmed.ncbi.nlm.nih.gov/160789/

[12] Bigland CH, Warenycia MW, Denson M. Specific immune gammaglobulin in the control of Mycoplasma meleagridis. Poult Sci. 1979. https://pubmed.ncbi.nlm.nih.gov/530904/

[13] Stipkovits L, Kempf I. Mycoplasmoses in poultry. Rev Sci Tech. 1996. https://pubmed.ncbi.nlm.nih.gov/9190023/

[14] Rhoades KR. Pathogenicity of strains of the IJKNQR group of avian mycoplasmas for turkey embryos and poults. Avian Dis. 1981. https://pubmed.ncbi.nlm.nih.gov/7271648/